246 related articles for article (PubMed ID: 16922470)
1. Synthesis and evaluation of vesamicol analog (-)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter.
Kawamura K; Shiba K; Tsukada H; Nishiyama S; Mori H; Ishiwata K
Ann Nucl Med; 2006 Jul; 20(6):417-24. PubMed ID: 16922470
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176
[TBL] [Abstract][Full Text] [Related]
3. The potential of (-)-o-[11C]methylvesamicol for diagnosing cholinergic deficit dementia.
Shiba K; Nishiyama S; Tsukada H; Ishiwata K; Kawamura K; Ogawa K; Mori H
Synapse; 2009 Feb; 63(2):167-71. PubMed ID: 19021207
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (+)-p-[11C]methylvesamicol for mapping sigma1 receptors: a comparison with [11C]SA4503.
Ishiwata K; Kawamura K; Yajima K; QingGeLeTu ; Mori H; Shiba K
Nucl Med Biol; 2006 May; 33(4):543-8. PubMed ID: 16720247
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H
Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200
[TBL] [Abstract][Full Text] [Related]
6. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M
Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305
[TBL] [Abstract][Full Text] [Related]
8. The potential of o-bromo-trans-decalinvesamicol as a new PET ligand for vesicular acetylcholine transporter imaging.
Azim MA; Kozaka T; Uno I; Miwa D; Kitamura Y; Ogawa K; Makino A; Kiyono Y; Shiba K
Synapse; 2014 Oct; 68(10):445-53. PubMed ID: 24953217
[TBL] [Abstract][Full Text] [Related]
9. (-)-o-[
Miwa D; Kitamura Y; Kozaka T; Shigeno T; Ogawa K; Taki J; Kinuya S; Shiba K
Synapse; 2020 Nov; 74(11):e22176. PubMed ID: 32500935
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
14. Development of novel PET probe [¹¹C](R,R)HAPT and its stereoisomer [¹¹C](S,S)HAPT for vesicular acetylcholine transporter imaging: a PET study in conscious monkey.
Nishiyama S; Ohba H; Kobashi T; Nakamasu Y; Nakao H; Ogata T; Kitashoji T; Tsukada H
Synapse; 2014 Jul; 68(7):283-92. PubMed ID: 24687885
[TBL] [Abstract][Full Text] [Related]
15. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
16. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preliminary evaluation of [11C]NE-100 labeled in two different positions as a PET sigma receptor ligand.
Ishiwata K; Noguchi J; Ishii S; Hatano K; Ito K; Nabeshima T; Senda M
Nucl Med Biol; 1998 Apr; 25(3):195-202. PubMed ID: 9620623
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.
Tu Z; Efange SM; Xu J; Li S; Jones LA; Parsons SM; Mach RH
J Med Chem; 2009 Mar; 52(5):1358-69. PubMed ID: 19203271
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.
Syvänen S; Eriksson J; Genchel T; Lindhe O; Antoni G; Långström B
BMC Med Imaging; 2007 Jul; 7():6. PubMed ID: 17663770
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of radioiodinated (-)-o-iodovesamicol as a radiotracer for mapping the vesicular acetylcholine transporter.
Shiba K; Mori H; Tonami N
Ann Nucl Med; 2003 Sep; 17(6):451-6. PubMed ID: 14575378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
